CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-02 | Lee Kevin CHIEF EXECUTIVE OFFICER | Grant or award | +123,200 | 504,064 | ||
| 2025-01-02 | Lee Kevin CHIEF EXECUTIVE OFFICER | Sale | −9,038 | $14.09 | $127K | 495,026 |
| 2025-01-02 | Lee Kevin CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +308,000 | 308,000 | ||
| 2025-01-02 | Winter Gregory Paul Director | Grant or award | +6,250 | 186,927 | ||
| 2025-01-02 | Winter Gregory Paul Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2025-01-02 | Sands Stephen H. Director | Grant or award | +5,393 | 17,393 | ||
| 2025-01-02 | Sands Stephen H. Director | Grant or award · Stock Option (right to buy) | +10,787 | 10,787 | ||
| 2025-01-02 | Kender Richard N Director | Grant or award | +6,250 | 23,000 | ||
| 2025-01-02 | Kender Richard N Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2025-01-02 | Gutierrez-Ramos Jose-Carlos Director | Grant or award | +6,250 | 23,000 | ||
| 2025-01-02 | Gutierrez-Ramos Jose-Carlos Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2025-01-02 | Bourque Janice Director | Grant or award | +6,250 | 23,000 | ||
| 2025-01-02 | Bourque Janice Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2025-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award | +4,400 | 918,483 | ||
| 2025-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award | +4,400 | 9,999,674 | ||
| 2025-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +8,801 | 8,801 | ||
| 2025-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +8,801 | 8,801 | ||
| 2024-12-16 | BAKER BROS. ADVISORS LP Director | Purchase | +42,369 | $15.34 | $650K | 914,083 |
| 2024-12-16 | BAKER BROS. ADVISORS LP Director | Purchase | +457,631 | $15.34 | $7.0M | 9,995,274 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +2,809 | $13.50 | $38K | 790,763 |
Page 9 of 26 · 520 trades